Genitourinary Cancer
Conference Coverage
AUA 2022: A report from the trenches
Hundreds of talks and abstracts were presented over the 4 days in New Orleans.
Conference Coverage
New guideline gives active surveillance a boost
This is the first guidance for localized prostate cancer since 2017.
Latest News
Doctor accused of ‘fraudulent concealment’ can’t be held liable
The Iowa Supreme Court dismissed a knotty claim against a local doctor and hospital accused of concealing a woman’s renal cancer.
Conference Coverage
Most men with low-risk prostate tumors now forgoing treatment
Roughly 60% of men eligible for active surveillance chose that approach in 2021, up from 27% in 2014 and less than 10% in 2010.
Diminutio
Dodging potholes from cancer care to hospice transitions
The consequences of suboptimal hospice transitions can damage the mental health and well-being of patient and caregiver.
From the Journals
Is it time to remove ‘cancer’ label from low-risk prostate tumors?
Experts argue that overtreatment could be reduced by removing the word “cancer” from low-risk disease.
From the Journals
Overuse of surveillance in bladder cancer, despite guidelines
Data suggest a need for ongoing efforts to limit overuse of treatment and surveillance.
Conference Coverage
Better survival in older cancer patients who take metformin
“It is important to explore optimal dosages that significantly improve cancer outcomes to boost anticancer effect.”
From the Journals
Obesity increasing the risk for cancer: It’s complicated
For some cancers it was “very clear that obesity increased the risk ... but for some other cancer types, we either don’t have enough data yet or...
From the Journals
Artificial sweeteners: A modifiable cancer risk?
“Our findings do not support the use of artificial sweeteners as safe alternatives for sugar in foods or beverages,” said the researchers. An...
From the Journals
Few new cancer drugs replace current standards of care
Newer drugs could benefit patients but could increase the cost of care.